Featured Articles

31. From Discovery To Commercial Promise With Philogen's Dr. Dario Neri 9/23/2022

    In a recent episode of The Business of Biotech, Philogen CEO Dr. Dario Neri sat down to explore his journey from academia to startups, as well as Philogen's own trajectory.

32. Rethinking Cancer Treatment With Anixa's Amit Kumar 8/18/2022

    Overcoming the hurdles of CAR-T therapy development for solid tumors will require novel science, innovative processing, and unshakeable optimism.

33. Pursuing Venture Philanthropy With Opus Genetics: The Business Of Biotech 8/10/2022

    Explore new, more agile approaches to overcoming the advanced therapy obstacles inherent to bringing rare disease treatments to market.

34. Surface Plasmon Resonance (SPR): Visualize Your Research 7/20/2022

    SPR technology provides robust results from difficult samples. Explore how 90% of responders are satisfied with the robustness and reproducibility of our systems. 

35. Biotin CAPture Kit Ready-To-Go Interaction Analysis 7/20/2022

    Explore how our Single Cycle Kinetics (SCK) regularly provides useful results on the first attempt and has a faster result time compared to Multi Cycle Kinetics (MCK) experiments.

36. Outstanding Sensitivity For Confident SPR Interaction Analysis 7/20/2022

    Explore how surface plasmon resonance (SPR)-based analyses with a high sensitivity instrument can provide greater data precision and better confidence in your results interpretation.

37. Regulatory Convergence With Aurion Biotech 5/18/2022

    Advanced therapeutics are as complex as they are promising. Establishing a global regulatory strategy for these modalities requires a comprehensive, multifaceted approach.

38. 3 Tips For Purifying His-Tagged Proteins 10/21/2021

    Tags simplify purification and enable scientists to use standard protocols while also improving the yield, purity, and solubility of the protein of interest.

39. bluebird Bio's Scott Cleve On New Therapies, New Regulatory Approaches 10/4/2021

    bluebird bio's Scott Cleve sat down with The Business of Biotech podcast to talk about shifting regulatory standards and how pharmas can adapt how they engage with regulators.

40. Increase Drug Discovery Productivity, Optimize SPR Data Interpretation 9/17/2021

    The need to increase efficiency and productivity has led scientists to develop a machine learning solution that can optimize the way that developers analyze and characterize their early drug candidates.